Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuichi Ando

Showing results (1-10 of 241) with videos related to

Pageof 25
Sort By:
Nagoya Journal of Medical Science|January 9, 2025
Greeting from the new editor-in-chiefYuichi Ando
Drug Metabolism Reviews|November 1, 2005
Clinical pharmacogenetics of irinotecan (CPT-11)Yuichi Ando, Yoshinori Hasegawa
Scientific Reports|October 14, 2020
Gap between pediatric and adult approvals of molecular targeted drugsSatoshi Nishiwaki, Yuichi Ando
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2023
Consent in Pharmacogenetic TestingYuichi Ando, Tomohiro Terada
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2024
<i>UGT1A1</i> Testing for the Risk of Nanoliposomal Irinotecan-Related ToxicityYao Liang, Yuichi Ando
Frontiers in Medicine|January 10, 2022
COVID-19 Pandemic and Trends in Clinical Trials: A Multi-Region and Global PerspectiveSatoshi Nishiwaki, Yuichi Ando
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 3, 2015
[Clinical pharmacology and toxicology of anticancer drugs]Yukiko Kato, Yuichi Ando
World Journal of Gastrointestinal Oncology|August 2, 2019
Recent progress of chemotherapy and biomarkers for gastroesophageal cancerOsamu Maeda, Yuichi Ando
The Lancet. Oncology|May 30, 2014
Carboplatin plus paclitaxel scheduling for advanced ovarian cancerTomoya Shimokata, Yuichi Ando
Journal of Global Oncology|November 9, 2019
Application of the New Process for Unapproved Drug Use: Dilemma of Universal Health Care Coverage in JapanSatoshi Nishiwaki, Yuichi Ando
Pageof 25

Showing results (1-10 of 241) with videos related to

Sort By:
Pageof 25
Nagoya Journal of Medical Science|January 9, 2025
Greeting from the new editor-in-chiefYuichi Ando
Drug Metabolism Reviews|November 1, 2005
Clinical pharmacogenetics of irinotecan (CPT-11)Yuichi Ando, Yoshinori Hasegawa
Scientific Reports|October 14, 2020
Gap between pediatric and adult approvals of molecular targeted drugsSatoshi Nishiwaki, Yuichi Ando
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2023
Consent in Pharmacogenetic TestingYuichi Ando, Tomohiro Terada
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2024
<i>UGT1A1</i> Testing for the Risk of Nanoliposomal Irinotecan-Related ToxicityYao Liang, Yuichi Ando
Frontiers in Medicine|January 10, 2022
COVID-19 Pandemic and Trends in Clinical Trials: A Multi-Region and Global PerspectiveSatoshi Nishiwaki, Yuichi Ando
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 3, 2015
[Clinical pharmacology and toxicology of anticancer drugs]Yukiko Kato, Yuichi Ando
World Journal of Gastrointestinal Oncology|August 2, 2019
Recent progress of chemotherapy and biomarkers for gastroesophageal cancerOsamu Maeda, Yuichi Ando
The Lancet. Oncology|May 30, 2014
Carboplatin plus paclitaxel scheduling for advanced ovarian cancerTomoya Shimokata, Yuichi Ando
Journal of Global Oncology|November 9, 2019
Application of the New Process for Unapproved Drug Use: Dilemma of Universal Health Care Coverage in JapanSatoshi Nishiwaki, Yuichi Ando
Pageof 25